ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2160

The Journey to Diagnosis in As/Axial Spondyloarthritis – the Psychological Impact of Delay

Jane Martindale1,2 and Lynne Goodacre2, 1Physiotherapy, Wrightington Wigan and Leigh NHS Foundation Trust, Wigan, United Kingdom, 2Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), diagnosis, psychological status and spondylarthropathy

  • Tweet
  • Email
  • Print
Session Information

Title: ARHP Osteoarthritis - Clinical Aspects: Psychology/Social Sciences

Session Type: Abstract Submissions (ARHP)

Background/Purpose:

It is not uncommon for 8 to 11 years to pass between symptoms onset and definitive diagnosis of AS/axial SpA (Gran 1997, Feldtkeller, 2003). We are not yet fully conversant with all of the factors influencing this delay. The aim of this study was to conduct an in-depth exploration of the ‘journey’ to diagnosis of people with AS/SpA to gain insights into the experience, potential barriers and facilitators in this process. 

Methods:

Ethical approval was obtained for a qualitative phenomenological study embedded within a longitudinal cohort study of people newly diagnosed with AS/AxialSpA in the UK. 10 participants from 2 sites meeting the inclusion criteria, gave consent to be interviewed at diagnosis utilising an in-depth semi-structured approach. Interviews were recorded and transcribed verbatim. Thematic analysis comprised an iterative, interpretative process in which a systematic and rigorous approach was used to ensure that codes, code frameworks and themes were grounded within the data, to ensure credibility and trustworthiness.

Results:

7 males and 3 females consented to participate; age mean (SD) 40.2 (7.7) years (range: 26 – 49), with reported years of symptoms before diagnosis being 10.1 (7.3) years.  Analysis identified 4 key themes:  ‘Trying to work out what was wrong’ describes the worry that was associated with knowing that something was wrong and how this was complicated by the variability and the severity of the back pain participants were experiencing. ‘Fighting for a diagnosis’ encompasses an overall sense that participants felt that their back pain was being dismissed. Participants described having to be persistent and ‘fighting’ to be referred to a specialist, and a sense that they were not being believed. ‘The impact of being given a diagnosis’ describes the contradictory emotions of relief and empowerment associated with being believed, and the worries and uncertainty about the future. ‘The impact of delayed diagnosis’ describes the negative psychological price that people paid including desperation, distress, depression and feeling disheartened.  For those in employment continuing to work had been challenging with the stigmatisation of a ‘bad back’. Insights were provided also into the emotional price paid by family members during this journey to diagnosis.

Conclusion:

These insights have identified that people endure a multiplicity of problems and psychological distress to achieve a diagnosis.  Delay in diagnosis may be associated with lack of familiarity and knowledge of AS/axial SpA by the population and healthcare professionals, highlighting the importance of campaigns to bring this condition to the public domain.  Clinicians need to consider the potential impact of the ‘journey to diagnosis’ on clinical management once a diagnosis has been made.


Disclosure:

J. Martindale,
None;

L. Goodacre,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-journey-to-diagnosis-in-asaxial-spondyloarthritis-the-psychological-impact-of-delay/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology